Stefanos Theoharis joins OneChain Immunotherapeutics (OCI) as new CEO. He follows Jorge Alemany, CEO since 2022, when the Spin-off from the Josep Carreras Leukemia Research Institute has started.
ADVERTISEMENT
Tag Archive for: Barcelona
After two years of unprecedented growth driven by the pandemic, investment attracted by Spanish biotech companies has stabilised, and they face significant challenges, positioning biotechnology as a strategic sector for Spain.